|
|
||||||||
Stanford University School of Medicine, Stanford, California
Correspondence: For reprints contact: I. R. McDougall, MB, PhD, Div. of Nuclear Medicine, Stanford Univ. School of Medicine, Stanford, CA 94305.
ABSTRACT
Free thyroxine (FT4) has been measured in two groups of patients, before and after heparin, using equilibrium dialysis (ED) and two radioimmunoassays, RIA-I and RIA-II. In Group A, nine patients were tested before and after 1224 hr of intravenous heparin. FT4 (ED) rose from 1.9 ± 0.5 to 2.8 ± 3.0 ng/dl, and RIA-I from 1.37 ± 0.37 to 1.89 ± 1.21 ng/dl, whereas RIA-II results fell from 0.97 ± 0.38 to 0.66 ± 0.32 ng/dl. In Group B, ten patients were tested before and after 15 min of intravenous heparin. FT4 (ED) rose from 1.7 ± 0.7 to 3.2 ± 1.6 ng/dl (P < 0.02), and RIA-I rose from 1.3 ± 0.46 to 2.02 ± 1.01 ng/dl (P < 0.05), whereas RIA-II results fell from 1.07 ± 0.38 to 0.63 ± 0.31 ng/dl (P < 0.02). The correlation coefficient between FT4 (ED) and RIA-I in 38 paired results was 0.96, but there was no correlation between FT4 (ED) and RIA-II results.
This article has been cited by other articles:
![]() |
M. Camici and L. Evangelisti Heparin and Prostacyclin Angiology, April 1, 1989; 40(4): 294 - 299. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |